2019 Spring ADRC Meeting
Biomarkers Special Emphasis Session
- Introduction to FDA's role in regulation of Alzheimer's diagnostic tests
- Doug Jeffery, PhD, Acting Deputy Division Director, Division of Immunology and Hematology Devices, Center for Devices and Radiological Health, U.S. Food & Drug Administration
Advances in clinical mass spectrometry and AD biomarker discovery
- Conformational proteomics (presentation unavailable)
- John Yates III, PhD, Professor, Department of Molecular Medicine, Scripps Research, San Diego, CA
- New proteomics strategies for studying Alzheimer's and related dementias
- Michael MacCoss, PhD, Professor of Genome Sciences, University of Washington
- Using targeted proteomic assays in the care of patients
- Andy Hoofnagle, MD, PhD, Professor, Department of Laboratory Medicine, University of Washington
- Start right in order to end right (presentation unavailable)
- Rebecca Van Eyk, PhD, Professor, Department of Biomedical Sciences, Cedars-Sinai, Los Angeles, CA
AMP-AD pilot biomarker discovery projects
- Introduction
- Laurie Ryan, PhD, Program Director, Chief, Dementias of Aging Branch, Division of Neuroscience, NIA/NIH
- Exploring the transcriptome for novel biomarker discovery
- Nilufer Ertekin-Taner, MD, PhD, Professor of Neuroscience and Neurology, Mayo Clinic, Jacksonville, FL
- Integrative proteomics for biomarker discovery in AD
- Nicholas Seyfried, PhD, Associate Profressor, Department of Biochemistry, Emory University, Atlanta, GA
- Targeted metabolomics of targeted and central mediators: Searching for peripheral biomarkers of central effects
- John Newman, PhD, Research Chemist, USDA, ARS, Western Human Nutrition Research Center, Davis, CA
Administrators Meeting
- Mary Sundsmo: Celebration of Life
- Participant burden
- Jennifer Lingler, PhD, ORE Core Leader, University of Pennsylvania
- Research registries
- Eric Reiman, MD, Director, Arizona ADRC
- The language of consents
- Kelley Faber, MD, CCRC, Manager, National Cell Repository for Alzheimer's Disease
- Return of results
- Neelum Aggarwal, MD, Clinical Core Leader, Rush University
- Data and specimen sharing
- John Gibbons, MS, Data Manager, Rush University
- Tatiana Foroud, PhD, PI, National Cell Repository for Alzheimer's Disease
Directors Meeting
- Directors Meeting presentation
- NIA updates
- Eliezer Masliah, MD, Director, Division of Neuroscience, NIA/NIH
- NIA updates
- Nina Silverberg, PhD, Director, ADRC Program, NIA/NIH
- NIA/OCPL update
- Joe Balintfy, Sr. Public Affairs Specialist, Alzheimer's and Related Dementias, NIA Office of Communications and Public Liaison, NIA/NIH
- Report from the ADRD Summit
- Julie Schneider, MD, MS, Scientific Chair, ADRD Summit; NP Core Leader, Rush University ADRC
Update of biomarkers and current status
- Planning for fluid biomarkers on a larger scale
- Tatiana Foroud, PhD, PI, National Cell Repositofy for Alzheimer's Disease
- Updates from the Alzheimer's Association Standardization of Blood Biomarkers Preanalytical Protocol Workgroup
- Rebecca Edelmeyer, PhD, Alzheimer's Association
Clinical Core Leaders Meeting
Vascular contributions to cognitive impairment: Are we ready for a "V" in the ATN framework?
- Welcome and overview of session
- Cindy Carlsson, MD, MS, Chair, ADRC Clinical Core Leaders Steering Committee, Clinical Core Leader, University of Wisconsin
- Biomarker Disclosure Workgroup, Research/Analysis Subcommittee: Framework for informing disclosure
- Deborah Blacker, MD, ScD, Clinical Core Leader, REC Leader, Massachusetts ADRC